Katarzyna Ruckemann-Dziurdzinska
Overview
Explore the profile of Katarzyna Ruckemann-Dziurdzinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cezary Czarnogorski M, Sakowska J, Maziewski M, Zielinski M, Piekarska A, Obuchowski I, et al.
Immun Ageing
. 2022 Nov;
19(1):51.
PMID: 36324179
Background: Ageing is a complex phenomenon that leads to decreased proliferative activity, loss of function of the cells, and cellular senescence. Senescence of the immune system exacerbates individual's immune response,...
2.
Luty J, Ruckemann-Dziurdzinska K, Witkowski J, Bryl E
Cytokine
. 2019 Feb;
116:128-133.
PMID: 30711852
Autoimmune thyroid disease (ATD) is a chronic autoimmune thyroiditis with a complex pathogenesis including environmental factors, genetic background and immune system actions. Despite the large-scale research and discovery of new...
3.
Sobjanek M, Zablotna M, Szczerkowska-Dobosz A, Ruckemann-Dziurdzinska K, Sokolowska-Wojdylo M, Nowicki R
Postepy Dermatol Alergol
. 2016 Nov;
33(5):381-385.
PMID: 27881944
Introduction: Polymorphic variants of and genes and their protein serum levels have been implicated in the increased risk and severity of several malignancies. However, the subject has not been explored...
4.
Mikosik A, Jasiulewicz A, Daca A, Henc I, Frackowiak J, Ruckemann-Dziurdzinska K, et al.
Oncotarget
. 2016 Nov;
7(47):76479-76495.
PMID: 27835610
The immune response is determined by the speed of the T cell reaction to antigens assured by a state of readiness for proliferation and cytokine secretion. Proliferation, apoptosis and motion...
5.
Sokolowska-Wojdylo M, Olek-Hrab K, Ruckemann-Dziurdzinska K
Postepy Dermatol Alergol
. 2016 Jan;
32(5):368-83.
PMID: 26759546
Primary cutaneous lymphomas (CLs) are a heterogeneous group of lymphoproliferative neoplasms, with lymphatic proliferation limited to the skin with no involvement of lymph nodes, bone marrow or viscera at the...
6.
Sobjanek M, Zablotna M, Bien E, Glen J, Sokolowska-Wojdylo M, Ruckemann-Dziurdzinska K, et al.
Biomark Med
. 2015 Nov;
10(2):185-95.
PMID: 26609634
Materials & Methods: Polymorphic variants of IL-2 gene (-330 T/G and +166 G/T), IL-10 gene (-1082 G/A and -819 C/T) and serum cytokines concentrations in the group of 179 patients...
7.
Binkiewicz-Glinska A, Bakula S, Tomczak H, Landowski J, Ruckemann-Dziurdzinska K, Zaborowska-Sapeta K, et al.
Psychiatr Pol
. 2015 Oct;
49(4):801-10.
PMID: 26488355
According to American College of Rheumatology fibromyalgia syndrome (FMS) is a common health problem characterized by widespread pain and tenderness. The pain and tenderness, although chronic, present a tendency to...
8.
Mikosik A, Henc I, Ruckemann-Dziurdzinska K, Frackowiak J, Ploszynska A, Balcerska A, et al.
PLoS One
. 2015 Aug;
10(8):e0136615.
PMID: 26317226
Childhood acute lymphoblastic leukemia (ALL) blasts are characterized by inhibited apoptosis promoting fast disease progress. It is known that in chronic lymphocytic and acute myeloid leukemias the reduced apoptosis is...
9.
Sokolowska-Wojdylo M, Glen J, Zablotna M, Rebala K, Trzeciak M, Sikorska M, et al.
Int J Dermatol
. 2014 Dec;
54(1):62-7.
PMID: 25534405
Background: Severe pruritus is one of the cardinal symptoms of atopic dermatitis (AD). Recently, the interleukin (IL)-31 cytokine has been implicated in the induction and maintenance of severe pruritus and...
10.
Malek M, Glen J, Rebala K, Kowalczyk A, Sobjanek M, Nowicki R, et al.
Acta Derm Venereol
. 2014 Sep;
95(3):283-8.
PMID: 25176053
Mycosis fungoides (MF) and Sézary syndrome (SS) belong to the group of primary cutaneous T-cell lymphomas (CTCL). Regardless of the stage of the disease, patients with MF and SS can...